Sonoma Pharmaceuticals, Inc. (SNOA) AI Dilution Summary

Cash was $5,338,000 at 2026-06-30 against estimated monthly burn of $216,333. The company's funding channel is an active ATM with Ladenburg Thalmann & Co. Inc., authorised to $3,641,703. Through 2026-06-18 it had sold 173,073 shares for $574,633 since the program began, and sales after 2026-06-18 are not yet reported.